HEADER ANTIBIOTIC 23-OCT-12 4HP2 TITLE INVARIOM REFINEMENT OF A NEW DIMERIC MONOCLINIC 2 SOLVATE OF TITLE 2 THIOSTREPTON AT 0.64 ANGSTROM RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: THIOSTREPTON; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 56-72; COMPND 5 SYNONYM: ALANINAMIDE, BRYAMYCIN, GARGON, THIACTIN SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: STREPTOMYCES AZUREUS; SOURCE 3 ORGANISM_TAXID: 146537; SOURCE 4 STRAIN: MST-AS4632 KEYWDS ANTIBIOTIC, THIOPEPTIDE, ANTIBACTERIAL, THIAZOLE, THIAZOLINE, KEYWDS 2 OXAZOLE, RIBOSOME, TRANSLATION INHIBITION EXPDTA X-RAY DIFFRACTION AUTHOR K.PROEPPER,J.J.HOLSTEIN,C.B.HUEBSCHLE,C.S.BOND,B.DITTRICH REVDAT 3 04-APR-18 4HP2 1 REMARK REVDAT 2 15-NOV-17 4HP2 1 REMARK REVDAT 1 02-OCT-13 4HP2 0 JRNL AUTH K.PROPPER,J.J.HOLSTEIN,C.B.HUBSCHLE,C.S.BOND,B.DITTRICH JRNL TITL INVARIOM REFINEMENT OF A NEW MONOCLINIC SOLVATE OF JRNL TITL 2 THIOSTREPTON AT 0.64 ANGSTROM RESOLUTION. JRNL REF ACTA CRYSTALLOGR.,SECT.D V. 69 1530 2013 JRNL REFN ISSN 0907-4449 JRNL PMID 23897476 JRNL DOI 10.1107/S0907444913010664 REMARK 2 REMARK 2 RESOLUTION. 0.64 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 0.64 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 91.0 REMARK 3 CROSS-VALIDATION METHOD : LEAST SQUARES REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.076 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.068 REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 72903 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : 0.076 REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : 0.068 REMARK 3 FREE R VALUE (F>4SIG(F)) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : 62211 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 228 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 70 REMARK 3 SOLVENT ATOMS : 2 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : NULL REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : NULL REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : NULL REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : NULL REMARK 3 NUMBER OF RESTRAINTS : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 ANGLE DISTANCES (A) : NULL REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : NULL REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : NULL REMARK 3 ZERO CHIRAL VOLUMES (A**3) : NULL REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : NULL REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : NULL REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : NULL REMARK 3 SIMILAR ADP COMPONENTS (A**2) : NULL REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: NULL REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : NULL REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4HP2 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 14-DEC-12. REMARK 100 THE DEPOSITION ID IS D_1000075741. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 7.00 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X10SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.65 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 X 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 72903 REMARK 200 RESOLUTION RANGE HIGH (A) : 0.640 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 91.0 REMARK 200 DATA REDUNDANCY : 3.610 REMARK 200 R MERGE (I) : 0.05050 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 16.8800 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 0.64 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 0.65 REMARK 200 COMPLETENESS FOR SHELL (%) : 46.4 REMARK 200 DATA REDUNDANCY IN SHELL : 0.67 REMARK 200 R MERGE FOR SHELL (I) : 0.14570 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.460 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: SHELXS/DIRECT-METHODS REMARK 200 SOFTWARE USED: SHELXL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 16.88 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.48 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: DIMETHYLFORMAMID, DIETHYLETHER, PH REMARK 280 7.00, VAPOR DIFFUSION REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 11.43500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 THIOSTREPTON IS A MEMBER OF A SULPHUR-RICH HETEROCYCLIC PEPTIDES REMARK 400 CLASS. ALL SHARE A MACROCYLIC CORE, CONSISTING OF A REMARK 400 NITROGEN CONTAINING, SIX-MEMBERED RING CENTRAL TO DEHYDROAMINO REMARK 400 ACIDS AND A SUBSET OF FIVE MEMBER RING STRUCTURES INCLUDING REMARK 400 THIAZOLES, THIAZOLINES AND OXAZOLES. REMARK 400 HERE, THIOSTREPTON IS REPRESENTED BY THE SEQUENCE (SEQRES) REMARK 400 REMARK 400 THE THIOSTREPTON IS THIOPEPTIDE, A MEMBER OF ANTIBIOTIC CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: THIOSTREPTON REMARK 400 CHAIN: A, B REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: Thiostrepton is a hetrocyclic thiopeptide belonging REMARK 400 to the thiocillin family, consisting of four REMARK 400 thiazole, one thiozoline and one piperideine rings. REMARK 400 A modified quinoline linked to main-chain residue 1 REMARK 400 and side-chain of residue 12. Post translational REMARK 400 maturation of thiazole and oxazole containing REMARK 400 antibiotics involves the enzymic condensation of a REMARK 400 Cys or Ser with the alpha-carbonyl of the preceding REMARK 400 amino acid to form a thioether or ether bond, then REMARK 400 dehydration to form a double bond with the alpha- REMARK 400 amino nitrogen. Thiazoline or oxazoline ring are REMARK 400 dehydrogenated to form thiazole or oxazole rings. REMARK 400 the pyridinyl involves the cross-linking of a Ser REMARK 400 and a Cys-Ser pair usually separated by 7 or 8 REMARK 400 residues along the peptide chain. The Ser residues REMARK 400 are dehydrated to didehydroalanines, then bonded REMARK 400 between their beta carbons. The alpha carbonyl of REMARK 400 the Cys condenses with alpha carbon of the first Ser REMARK 400 to form a pyridinyl ring. The ring may be mutiply REMARK 400 dehydrogenated to form a pyridine ring with loss of REMARK 400 the amino nitrogen of the first Ser. The amidation REMARK 400 of Ser-17 probably does not occur by the same REMARK 400 mechanism, oxidative cleavage of glycine, as in REMARK 400 eukaryotes. REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 SER A 6 OG REMARK 470 SER B 6 OG REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 C TS9 B 11 SG BB9 B 12 1.72 REMARK 500 C TS9 A 11 SG BB9 A 12 1.72 REMARK 500 C SER A 6 SG BB9 A 7 1.74 REMARK 500 C DBU A 9 SG DCY A 10 1.77 REMARK 500 C DBU B 9 SG DCY B 10 1.78 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 ALA A 5 C SER A 6 N 0.146 REMARK 500 THR A 13 N THR A 13 CA -0.319 REMARK 500 BB9 A 14 C MH6 A 15 N 0.147 REMARK 500 BB9 A 16 C DHA A 17 N 0.179 REMARK 500 BB9 B 14 C MH6 B 15 N 0.139 REMARK 500 BB9 B 14 C MH6 B 15 N 0.167 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 THR A 13 CA - CB - CG2 ANGL. DEV. = 17.8 DEGREES REMARK 500 BB9 A 16 O - C - N ANGL. DEV. = -13.1 DEGREES REMARK 500 DHA A 18 O - C - N ANGL. DEV. = 11.7 DEGREES REMARK 500 BB9 B 14 C - N - CA ANGL. DEV. = -16.9 DEGREES REMARK 500 BB9 B 16 C - N - CA ANGL. DEV. = -18.6 DEGREES REMARK 500 BB9 B 16 CA - C - N ANGL. DEV. = -18.9 DEGREES REMARK 500 BB9 B 16 O - C - N ANGL. DEV. = 10.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 6 76.83 70.39 REMARK 500 SER A 6 90.67 63.26 REMARK 500 DCY A 10 -30.85 -147.18 REMARK 500 TS9 A 11 -69.90 -90.27 REMARK 500 SER B 6 77.88 66.33 REMARK 500 SER B 6 77.17 56.52 REMARK 500 DCY B 10 -34.36 -146.89 REMARK 500 TS9 B 11 -72.69 -82.61 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 BB9 B 14 MH6 B 15 146.21 REMARK 500 BB9 B 14 MH6 B 15 148.97 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE QUA A 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NH2 A 19 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE QUA B 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NH2 B 19 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DMF A 101 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DMF A 102 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ETZ A 103 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ETZ A 104 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ETZ A 105 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ETZ A 106 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ETZ A 107 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DMF A 108 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DMF B 101 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DMF B 102 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DMF B 103 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DMF B 104 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DMF B 105 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ETZ B 106 REMARK 800 REMARK 800 SITE_IDENTIFIER: CC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN A OF THIOSTREPTON REMARK 800 REMARK 800 SITE_IDENTIFIER: CC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN B OF THIOSTREPTON REMARK 999 REMARK 999 SEQUENCE REMARK 999 A MODIFIED QUINOLINE QUA LINKED TO THE MAIN-CHAIN OF ILE 2 AND THE REMARK 999 SIDE-CHAIN OF THR 13. BB9 14 INCLUDES HYDROGEN ATOM H6, THE REMARK 999 DEHYDROPIPERIDINE CORE HYDROGEN POSITION AT THE SIX MEMBER RING REMARK 999 SYSTEM AMONG SER 6, BB9 14 AND MH6 15. DBREF 4HP2 A 2 18 UNP P0C8P8 THCL_STRAJ 56 72 DBREF 4HP2 B 2 18 UNP P0C8P8 THCL_STRAJ 56 72 SEQADV 4HP2 QUA A 1 UNP P0C8P8 SEE REMARK 999 SEQADV 4HP2 NH2 A 19 UNP P0C8P8 AMIDATION SEQADV 4HP2 QUA B 1 UNP P0C8P8 SEE REMARK 999 SEQADV 4HP2 NH2 B 19 UNP P0C8P8 AMIDATION SEQRES 1 A 19 QUA ILE ALA DHA ALA SER BB9 THR DBU DCY TS9 BB9 THR SEQRES 2 A 19 BB9 MH6 BB9 DHA DHA NH2 SEQRES 1 B 19 QUA ILE ALA DHA ALA SER BB9 THR DBU DCY TS9 BB9 THR SEQRES 2 B 19 BB9 MH6 BB9 DHA DHA NH2 MODRES 4HP2 DHA A 4 SER 2-AMINO-ACRYLIC ACID MODRES 4HP2 BB9 A 7 CYS MODRES 4HP2 DBU A 9 THR (2Z)-2-AMINOBUT-2-ENOIC ACID MODRES 4HP2 TS9 A 11 ILE MODRES 4HP2 BB9 A 12 CYS MODRES 4HP2 BB9 A 14 CYS MODRES 4HP2 MH6 A 15 SER 3-HYDROXY-2-IMINOPROPANOIC ACID MODRES 4HP2 BB9 A 16 CYS MODRES 4HP2 DHA A 17 SER 2-AMINO-ACRYLIC ACID MODRES 4HP2 DHA A 18 SER 2-AMINO-ACRYLIC ACID MODRES 4HP2 DHA B 4 SER 2-AMINO-ACRYLIC ACID MODRES 4HP2 BB9 B 7 CYS MODRES 4HP2 DBU B 9 THR (2Z)-2-AMINOBUT-2-ENOIC ACID MODRES 4HP2 TS9 B 11 ILE MODRES 4HP2 BB9 B 12 CYS MODRES 4HP2 BB9 B 14 CYS MODRES 4HP2 MH6 B 15 SER 3-HYDROXY-2-IMINOPROPANOIC ACID MODRES 4HP2 BB9 B 16 CYS MODRES 4HP2 DHA B 17 SER 2-AMINO-ACRYLIC ACID MODRES 4HP2 DHA B 18 SER 2-AMINO-ACRYLIC ACID HET QUA A 1 27 HET DHA A 4 8 HET BB9 A 7 7 HET DBU A 9 10 HET DCY A 10 9 HET TS9 A 11 20 HET BB9 A 12 7 HET BB9 A 14 14 HET MH6 A 15 12 HET BB9 A 16 14 HET DHA A 17 16 HET DHA A 18 16 HET NH2 A 19 6 HET QUA B 1 27 HET DHA B 4 8 HET BB9 B 7 14 HET DBU B 9 10 HET DCY B 10 9 HET TS9 B 11 20 HET BB9 B 12 7 HET BB9 B 14 12 HET MH6 B 15 12 HET BB9 B 16 14 HET DHA B 17 16 HET DHA B 18 16 HET NH2 B 19 6 HET DMF A 101 24 HET DMF A 102 24 HET ETZ A 103 15 HET ETZ A 104 15 HET ETZ A 105 30 HET ETZ A 106 15 HET ETZ A 107 15 HET DMF A 108 24 HET DMF B 101 12 HET DMF B 102 12 HET DMF B 103 24 HET DMF B 104 12 HET DMF B 105 12 HET ETZ B 106 15 HETNAM QUA 8-HYDROXY-4-(1-HYDROXYETHYL)QUINOLINE-2-CARBOXYLIC ACID HETNAM DHA 2-AMINO-ACRYLIC ACID HETNAM BB9 (2Z)-2-AMINO-3-SULFANYLPROP-2-ENOIC ACID HETNAM DBU (2Z)-2-AMINOBUT-2-ENOIC ACID HETNAM DCY D-CYSTEINE HETNAM TS9 (2S,3S,4R)-2-AMINO-3,4-DIHYDROXY-3-METHYLPENTANOIC ACID HETNAM MH6 3-HYDROXY-2-IMINOPROPANOIC ACID HETNAM NH2 AMINO GROUP HETNAM DMF DIMETHYLFORMAMIDE HETNAM ETZ DIETHYL ETHER HETSYN DHA 2,3-DIDEHYDROALANINE HETSYN DBU Z-DEHYDROBUTYRINE FORMUL 1 QUA 2(C12 H13 N O4) FORMUL 1 DHA 6(C3 H5 N O2) FORMUL 1 BB9 8(C3 H5 N O2 S) FORMUL 1 DBU 2(C4 H7 N O2) FORMUL 1 DCY 2(C3 H7 N O2 S) FORMUL 1 TS9 2(C6 H13 N O4) FORMUL 1 MH6 2(C3 H5 N O3) FORMUL 1 NH2 2(H2 N) FORMUL 3 DMF 8(C3 H7 N O) FORMUL 5 ETZ 6(C4 H10 O) FORMUL 17 HOH *2(H2 O) LINK C11 QUA A 1 OG1CTHR A 13 1555 1555 1.36 LINK C11 QUA A 1 OG1DTHR A 13 1555 1555 1.31 LINK C11 QUA B 1 OG1 THR B 13 1555 1555 1.34 LINK C7 QUA A 1 N ILE A 2 1555 1555 1.47 LINK C7 QUA B 1 N ILE B 2 1555 1555 1.46 LINK C ALA A 3 N DHA A 4 1555 1555 1.34 LINK C DHA A 4 N ALA A 5 1555 1555 1.35 LINK C SER A 6 N BB9 A 7 1555 1555 1.30 LINK C BB9 A 7 N THR A 8 1555 1555 1.35 LINK C THR A 8 N DBU A 9 1555 1555 1.36 LINK C DBU A 9 N DCY A 10 1555 1555 1.28 LINK C DCY A 10 N TS9 A 11 1555 1555 1.35 LINK C TS9 A 11 N BB9 A 12 1555 1555 1.30 LINK C BB9 A 12 N CTHR A 13 1555 1555 1.34 LINK C BB9 A 12 N DTHR A 13 1555 1555 1.42 LINK C CTHR A 13 N CBB9 A 14 1555 1555 1.30 LINK C DTHR A 13 N DBB9 A 14 1555 1555 1.32 LINK C CBB9 A 14 N CMH6 A 15 1555 1555 1.48 LINK C DBB9 A 14 N DMH6 A 15 1555 1555 1.46 LINK C CMH6 A 15 N CBB9 A 16 1555 1555 1.31 LINK C DMH6 A 15 N DBB9 A 16 1555 1555 1.32 LINK C CBB9 A 16 N CDHA A 17 1555 1555 1.33 LINK C DBB9 A 16 N DDHA A 17 1555 1555 1.52 LINK C CDHA A 17 N CDHA A 18 1555 1555 1.33 LINK C DDHA A 17 N DDHA A 18 1555 1555 1.34 LINK C CDHA A 18 N CNH2 A 19 1555 1555 1.27 LINK C DDHA A 18 N DNH2 A 19 1555 1555 1.38 LINK C ALA B 3 N DHA B 4 1555 1555 1.36 LINK C DHA B 4 N ALA B 5 1555 1555 1.35 LINK C ASER B 6 N ABB9 B 7 1555 1555 1.30 LINK C BSER B 6 N BBB9 B 7 1555 1555 1.31 LINK C ABB9 B 7 N THR B 8 1555 1555 1.33 LINK C BBB9 B 7 N THR B 8 1555 1555 1.40 LINK C THR B 8 N DBU B 9 1555 1555 1.36 LINK C DBU B 9 N DCY B 10 1555 1555 1.28 LINK C DCY B 10 N TS9 B 11 1555 1555 1.35 LINK C TS9 B 11 N BB9 B 12 1555 1555 1.30 LINK C BB9 B 12 N THR B 13 1555 1555 1.36 LINK C ATHR B 13 N ABB9 B 14 1555 1555 1.28 LINK C BTHR B 13 N BBB9 B 14 1555 1555 1.41 LINK C ABB9 B 14 N AMH6 B 15 1555 1555 1.48 LINK C BBB9 B 14 N BMH6 B 15 1555 1555 1.50 LINK C AMH6 B 15 N ABB9 B 16 1555 1555 1.29 LINK C BMH6 B 15 N BBB9 B 16 1555 1555 1.28 LINK C ABB9 B 16 N ADHA B 17 1555 1555 1.36 LINK C BBB9 B 16 N BDHA B 17 1555 1555 1.32 LINK C ADHA B 17 N ADHA B 18 1555 1555 1.35 LINK C BDHA B 17 N BDHA B 18 1555 1555 1.36 LINK C ADHA B 18 N ANH2 B 19 1555 1555 1.31 LINK C BDHA B 18 N BNH2 B 19 1555 1555 1.28 SITE 1 AC1 13 ILE A 2 ALA A 3 DHA A 4 ALA A 5 SITE 2 AC1 13 SER A 6 BB9 A 7 THR A 8 TS9 A 11 SITE 3 AC1 13 THR A 13 BB9 A 14 HOH A 201 QUA B 1 SITE 4 AC1 13 BB9 B 7 SITE 1 AC2 5 DHA A 18 ETZ A 103 ETZ A 104 ETZ A 107 SITE 2 AC2 5 ETZ B 106 SITE 1 AC3 13 QUA A 1 BB9 A 7 HOH A 202 ILE B 2 SITE 2 AC3 13 ALA B 3 DHA B 4 ALA B 5 SER B 6 SITE 3 AC3 13 BB9 B 7 THR B 8 TS9 B 11 THR B 13 SITE 4 AC3 13 BB9 B 14 SITE 1 AC4 7 DMF A 102 ETZ A 103 DCY B 10 BB9 B 12 SITE 2 AC4 7 DHA B 18 DMF B 104 ETZ B 106 SITE 1 AC5 4 ALA A 3 DHA A 4 ALA B 3 DHA B 4 SITE 1 AC6 13 ALA A 5 SER A 6 BB9 A 12 THR A 13 SITE 2 AC6 13 BB9 A 14 BB9 A 16 DHA A 18 ETZ A 106 SITE 3 AC6 13 DCY B 10 DHA B 18 NH2 B 19 DMF B 105 SITE 4 AC6 13 ETZ B 106 SITE 1 AC7 8 NH2 A 19 ETZ A 107 DCY B 10 BB9 B 12 SITE 2 AC7 8 BB9 B 14 DHA B 18 NH2 B 19 ETZ B 106 SITE 1 AC8 7 THR A 8 BB9 A 12 BB9 A 14 DHA A 18 SITE 2 AC8 7 NH2 A 19 ETZ A 107 ETZ B 106 SITE 1 AC9 2 ALA A 5 BB9 A 16 SITE 1 BC1 4 BB9 A 12 DMF A 102 DMF B 103 DMF B 105 SITE 1 BC2 8 DBU A 9 DCY A 10 DHA A 18 NH2 A 19 SITE 2 BC2 8 ETZ A 103 ETZ A 104 DMF A 108 DHA B 18 SITE 1 BC3 4 DHA A 18 ETZ A 107 DHA B 18 DMF B 101 SITE 1 BC4 5 DMF A 108 DHA B 17 DHA B 18 DMF B 102 SITE 2 BC4 5 DMF B 104 SITE 1 BC5 6 DHA A 17 ALA B 5 DHA B 17 DHA B 18 SITE 2 BC5 6 DMF B 101 DMF B 104 SITE 1 BC6 5 BB9 A 16 ETZ A 106 SER B 6 BB9 B 14 SITE 2 BC6 5 DMF B 105 SITE 1 BC7 6 DCY B 10 DHA B 17 DHA B 18 NH2 B 19 SITE 2 BC7 6 DMF B 101 DMF B 102 SITE 1 BC8 7 BB9 A 12 BB9 A 16 DMF A 102 ETZ A 106 SITE 2 BC8 7 BB9 B 14 MH6 B 15 DMF B 103 SITE 1 BC9 9 NH2 A 19 DMF A 102 ETZ A 103 ETZ A 104 SITE 2 BC9 9 THR B 8 DBU B 9 DCY B 10 BB9 B 12 SITE 3 BC9 9 NH2 B 19 SITE 1 CC1 25 QUA A 1 NH2 A 19 DMF A 101 DMF A 102 SITE 2 CC1 25 ETZ A 104 ETZ A 105 ETZ A 106 ETZ A 107 SITE 3 CC1 25 DMF A 108 HOH A 201 HOH A 202 QUA B 1 SITE 4 CC1 25 ILE B 2 ALA B 3 TS9 B 11 BB9 B 12 SITE 5 CC1 25 THR B 13 MH6 B 15 BB9 B 16 DHA B 17 SITE 6 CC1 25 DHA B 18 NH2 B 19 DMF B 102 DMF B 103 SITE 7 CC1 25 DMF B 105 SITE 1 CC2 25 QUA A 1 ILE A 2 TS9 A 11 BB9 A 12 SITE 2 CC2 25 THR A 13 MH6 A 15 BB9 A 16 DHA A 17 SITE 3 CC2 25 DHA A 18 NH2 A 19 DMF A 101 DMF A 102 SITE 4 CC2 25 ETZ A 103 ETZ A 107 DMF A 108 HOH A 201 SITE 5 CC2 25 HOH A 202 QUA B 1 NH2 B 19 DMF B 101 SITE 6 CC2 25 DMF B 102 DMF B 103 DMF B 104 DMF B 105 SITE 7 CC2 25 ETZ B 106 CRYST1 21.394 22.870 22.780 90.00 106.45 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.046742 0.000000 0.013801 0.00000 SCALE2 0.000000 0.043725 0.000000 0.00000 SCALE3 0.000000 0.000000 0.045772 0.00000 HETATM 1 O12 QUA A 1 10.531 12.814 3.003 1.00 4.90 O ANISOU 1 O12 QUA A 1 364 377 397 147 97 67 O HETATM 2 C11 QUA A 1 10.064 13.869 2.669 1.00 3.26 C ANISOU 2 C11 QUA A 1 282 359 325 83 29 -7 C HETATM 3 C2 QUA A 1 10.477 14.587 1.415 1.00 3.04 C ANISOU 3 C2 QUA A 1 290 300 310 70 23 3 C HETATM 4 N1 QUA A 1 9.732 15.630 1.001 1.00 3.10 N ANISOU 4 N1 QUA A 1 285 298 331 76 20 3 N HETATM 5 C3 QUA A 1 11.624 14.163 0.753 1.00 3.28 C ANISOU 5 C3 QUA A 1 325 282 364 91 15 -5 C HETATM 6 C9 QUA A 1 10.140 16.286 -0.090 1.00 2.68 C ANISOU 6 C9 QUA A 1 338 247 342 36 -10 -11 C HETATM 7 C4 QUA A 1 12.061 14.852 -0.374 1.00 3.11 C ANISOU 7 C4 QUA A 1 318 286 374 39 53 -27 C HETATM 8 C8 QUA A 1 9.343 17.504 -0.523 1.00 2.91 C ANISOU 8 C8 QUA A 1 347 255 389 54 -28 0 C HETATM 9 C10 QUA A 1 11.301 15.961 -0.805 1.00 2.92 C ANISOU 9 C10 QUA A 1 372 280 339 21 6 0 C HETATM 10 O16 QUA A 1 9.940 18.662 0.084 1.00 3.02 O ANISOU 10 O16 QUA A 1 340 294 432 40 -8 -25 O HETATM 11 C7 QUA A 1 9.389 17.709 -2.035 1.00 3.23 C ANISOU 11 C7 QUA A 1 445 278 371 36 -22 16 C HETATM 12 C13 QUA A 1 13.262 14.384 -1.173 1.00 3.67 C ANISOU 12 C13 QUA A 1 337 342 370 64 81 -13 C HETATM 13 O15 QUA A 1 14.095 13.512 -0.422 1.00 3.99 O ANISOU 13 O15 QUA A 1 367 360 380 97 95 -32 O HETATM 14 C5 QUA A 1 11.679 16.783 -1.944 1.00 3.79 C ANISOU 14 C5 QUA A 1 395 326 468 1 44 38 C HETATM 15 C14 QUA A 1 12.764 13.633 -2.411 1.00 3.72 C ANISOU 15 C14 QUA A 1 462 412 390 66 33 -64 C HETATM 16 C6 QUA A 1 10.804 17.632 -2.518 1.00 4.15 C ANISOU 16 C6 QUA A 1 487 328 406 19 27 86 C HETATM 17 HC3 QUA A 1 12.171 13.299 1.106 1.00 3.35 H HETATM 18 HC8 QUA A 1 8.302 17.409 -0.190 1.00 3.42 H HETATM 19 H16 QUA A 1 9.487 18.865 0.906 1.00 4.57 H HETATM 20 HC72 QUA A 1 8.976 18.701 -2.278 1.00 3.79 H HETATM 21 H13 QUA A 1 13.849 15.256 -1.488 1.00 3.57 H HETATM 22 H15 QUA A 1 14.619 14.028 0.197 1.00 4.80 H HETATM 23 HC5 QUA A 1 12.690 16.719 -2.334 1.00 4.06 H HETATM 24 H141 QUA A 1 12.184 14.316 -3.035 1.00 5.46 H HETATM 25 H142 QUA A 1 12.132 12.797 -2.105 1.00 5.46 H HETATM 26 H143 QUA A 1 13.620 13.257 -2.973 1.00 5.46 H HETATM 27 HC6 QUA A 1 11.132 18.258 -3.344 1.00 4.23 H